Mar 12, 2024
High School Seniors Win $1.8 Million at Regeneron Science Talent Search 2024 for Innovative Scientific Research on Artificial Intelligence, Cancer Metabolism and Mathematical Optimization
Jun 17, 2020
ISA Pharmaceuticals Strengthens Strategic Immuno-Oncology Collaboration With Regeneron
Dec 18, 2019
Quantum Leap Healthcare Collaborative Announces the Selection of Regeneron's Libtayo® (cemiplimab) and REGN3767 for Injection in the I-SPY 2 TRIAL for Breast Cancer
Nov 12, 2019
Regeneron Announces Upcoming Investor Conference Presentations
Nov 07, 2019
Global Dermatitis Market Is Expected to Grow at a CAGR of Approximately 9% Over 2018-2022: The Business Research Company
Nov 06, 2019
Regeneron and Vyriad Announce Strategic Agreement for Discovery and Development of New Oncolytic Virus Treatments for Cancer
Nov 06, 2019
Regeneron to Report Results from CD20xCD3 and BCMAxCD3 Bispecifics and C5 Antibody Programs at ASH Annual meeting
Nov 05, 2019
Regeneron Reports Third Quarter 2019 Financial and Operating Results
Oct 18, 2019
Regeneron Announces Upcoming Investor Conference Presentations
Oct 10, 2019
Regeneron to Report Third Quarter 2019 Financial and Operating Results and Host Conference Call and Webcast on November 5, 2019
Sep 20, 2019
CHMP Recommends Approval of Dupixent® (dupilumab) for Severe Chronic Rhinosinusitis with Nasal Polyposis
Sep 18, 2019
Educational Campaign Helps Teens and Their Caregivers Tackle Everyday Challenges of Living with Moderate-to-severe Atopic Dermatitis
Aug 28, 2019
U.S. District Court Invalidates Amgen Patent Claims Targeting PCSK9
Aug 15, 2019
Regeneron Announces Upcoming Investor Conference Presentation
Aug 12, 2019
PALM Ebola Clinical Trial Stopped Early as Regeneron's REGN-EB3 Therapy Shows Superiority to ZMapp in Preventing Ebola Deaths
Aug 06, 2019
Dupixent® (dupilumab) Approved by European Commission for Adolescents with Moderate-to-Severe Atopic Dermatitis
Aug 06, 2019
Dupixent® (dupilumab) Showed Positive Topline Results in Phase 3 Trial of Children Aged 6 to 11 Years with Severe Atopic Dermatitis
Aug 06, 2019
Regeneron Reports Second Quarter 2019 Financial and Operating Results
Jul 29, 2019
Sanofi delivered solid growth in Q2 2019
Jul 18, 2019
Society for Science & the Public Creates New Honorary Board